Inhibrx's (INBX) 'Data Disclosures Leave us Guessing' - Citizens Dec 17, 2025 04:58AM
INHIBRX Biosciences updates progress on cancer drug trials Dec 16, 2025 05:00PM
Inhibrx Biosciences' (INBX) Ozekibart, INBRX-106 are Lined-up For 2026 - Citizens Nov 19, 2025 04:19AM
Inhibrx, Inc. (INBX) Misses Q3 EPS by 71c Nov 14, 2025 06:14AM
Inhibrx drug meets primary endpoint in rare bone cancer trial Oct 23, 2025 04:08PM


Aug 22, 2025 04:03AM Citizens JMP Reiterates Market Perform Rating on Inhibrx Biosciences (INBX)
Aug 13, 2025 05:58PM Inhibrx, Inc. (INBX) Misses Q2 EPS by 30c
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 15, 2025 05:24PM Inhibrx, Inc. (INBX) Tops Q1 EPS by 421c
Apr 1, 2025 04:06PM Inhibrx Inc. (INBX) announces CSO change and appoints new President
Mar 18, 2025 04:07AM Citizens JMP Reiterates Market Perform Rating on Inhibrx Biosciences (INBX)
Jan 21, 2025 05:01PM Inhibrx Inc. (INBX) Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer
Jan 13, 2025 04:16PM Inhibrx Inc. (INBX) Announces Loan Agreement with Oxford Finance
Nov 15, 2024 07:09AM Inhibrx, Inc. (INBX) Misses Q3 EPS by 136c
Jul 23, 2024 03:03AM JMP Securities Starts Inhibrx Biosciences. (INBX) at Market Perform
Jun 11, 2024 05:15PM Inhibrx Inc. (INBX) Files for 2.45M Share Offering by Selling Stockholders